Ahmedabad-based Lincoln Pharmaceuticals has been awarded a patent for 'An Arteether Injection for Treatment of Malaria' by Government of India for Antimalaria Drug.
The drug is painless and gives faster relief to the patients, Lincoln Pharma said. The company expects significant rise in the revenue from exports to Africa after the introduction of this injection in the African market.
Parasite that causes Malaria can be Blocked
New ways to combat deadly diseases like malaria can be developed by blocking the malaria parasite with the inhibition of eukaryotic translation initiation factor-2 (eIF2) kinase.
Advertisement
‘Lincoln Pharmaceuticals has developed a painless Injection to treat malaria with compressed dosage form by reducing inside drug material up to 50% volume.’
Tweet it Now
This new Arteether Injection developed by the Company is available in 1ml only. Due to this new innovation, patients will get faster relief and painless. The results of this new Arteether Injection are far better than the other existing dosages form available in the market.
The company has received Patent No 258915 for the invention, it said. Lincoln Pharma said the invention will help it increase its presence in Africa, already a big market for the company.
![New Agenda to Eliminate and Eradicate Malaria]( "New Agenda to Eliminate and Eradicate Malaria")
A new framework for malaria elimination and eradication have been announced and World Health Organization (WHO) recommends every country to follow the new agenda.
"With the introduction of this injection in African countries, where total anti-malarial market is Rs 586 crore, the company expects to increase revenue from Africa by Rs 35-40 crore," it added.
The majority of African countries use similar injections to control malaria. The total anti-malarial market in African Countries are estimated Rs 586 crore, said the company.
Source: Medindia
New Agenda to Eliminate and Eradicate Malaria
A new framework for malaria elimination and eradication have been announced and World Health Organization (WHO) recommends every country to follow the new agenda.
Advertisement
"With the introduction of this injection in African countries, where total anti-malarial market is Rs 586 crore, the company expects to increase revenue from Africa by Rs 35-40 crore," it added.
The majority of African countries use similar injections to control malaria. The total anti-malarial market in African Countries are estimated Rs 586 crore, said the company.
Source: Medindia
15 Countries Accounted for 80% of All Malaria Cases Globally
India also witnessed a total of 331 malaria deaths in 2016, making it the highest in the entire Southeast Asia region.
Advertisement
New Malaria Parasite Identified in Wild BonobosNot finding any evidence of malaria in wild bonobos just didn't make sense, given that captive bonobos are susceptible to this infection. | Advertisement
|
Advertisement
Recommended Reading
Latest Drug News
The CDSCO has approved the intravenous administration of AstraZeneca Pharma India's liver cancer drug, Tremelimumab Concentrate.
The FDA advises consumers not to use compounded medications as an alternative to known diabetic and weight reduction medications Ozempic, Rybelsus, and Wegovy.
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.